Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1Phase 2 1

Status

Completed 23Unknown 6Active not recruiting 6Terminated 5Recruiting 5Withdrawn 4Not yet recruiting 3

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1CNS 1Breast 1

Conditions

Neoplasms 2Neurofibromatosis 1 1Carcinoma, Renal Cell 1Cachexia 1Breast Neoplasms 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Interventional × Dietary Supplements × Clear all
NCT05119010 2024-12-05

KETOREIN

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Terminated
3 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01968590 2022-05-25

VitDBoneNF1

University of Utah

Phase 2 Terminated
26 enrolled
CNS

Neurofibromatosis 1

NCT02590107 2018-05-15

Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant

Case Comprehensive Cancer Center

Phase NA Terminated
5 enrolled
Tumor-Agnostic

Neoplasms

NCT01548534 2015-07-29

DHALYA

University Hospital, Tours

Phase 3 Terminated
65 enrolled
Breast

Breast Neoplasms

NCT00851448 2011-06-02

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients

Fresenius Kabi

Phase NA Terminated
17 enrolled

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡